Beam stock forecast.

Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ...REINHARDT KRAUSE. 12:05 PM ET 10/25/2023. The best 5G stocks will evolve over time as business services delivered via cloud computing add new opportunities for wireless firms. But the 5G ...Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.14,305.03 +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Beam Therapeutics Inc. (BEAM) NasdaqGS - NasdaqGS Real Time Price.... The upgrade of Beam Therapeutics Inc. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ...

Jul 15, 2023 · Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ... 7 brokerages have issued 1 year target prices for Verve Therapeutics' stock. Their VERV share price targets range from $13.00 to $55.00. On average, they expect the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 147.5% from the stock's current price. View analysts price targets for VERV or view top ...Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

Nov 23, 2023 · Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years. Find the latest Quantum-Si incorporated (QSI) stock quote, history, news and other vital information to help you with your stock trading and investing.

(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as ...Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Schrodinger Inc have a median target of 47.00, with a high estimate of 80.00 and a low estimate of 29.00. The median ...Find real-time AVGO - Broadcom Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $10.95: Annual revenue (last year) $33.2B: Annual profit ...That’s the promise investors like Cathie Wood see in BEAM stock. The science is not yet at that level, though, and Beam Therapeutics lost more than a quarter of a billion dollars in 2022.

The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak .

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.

GLBE Stock 12 Months Forecast. $46.11. (31.33% Upside) Based on 9 Wall Street analysts offering 12 month price targets for Global-e Online in the last 3 months. The average price target is $46.11 with a high forecast of $50.00 and a low forecast of $41.00. The average price target represents a 31.33% change from the last price of $35.11.Find the latest Altimmune, Inc. (ALT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...When planning outdoor activities or making travel arrangements, having access to accurate weather forecasts is crucial. One commonly used tool is the 7 day weather forecast, which provides an outlook for the upcoming week.See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.The current average BEAM price target, as estimated by these analysts, is $63.00. The predictions for the future BEAM stock price range from a low of $62.00 to a high of $66.00, highlighting the variability of market expectations for BEAM.

As for the stock performance of Beam Therapeutics, on October 2nd, it opened at $24.05. Over the past 50 days, the stock has exhibited a moving average price of $25.47, while its 200-day moving average stands at $29.78. It is worth noting that BEAM’s fifty-two week low is reported to be $22.52, with a high point of $54.30 during the same period.When builders want to create something sturdy and attractive, like a bridge that spans a large river or a tall skyscraper, they must rely on structural steel. Made up mostly of beams, structural steel comes in dozens of standard beam sizes....Nov 29, 2023 · See the latest Beam Global stock price (BEEM:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Nov 29, 2023 · The Fly Beam Therapeutics price target lowered to $26 from $35 at Barclays. 21d ago. Press Releases Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results. 22d ago. Press Releases Beam Therapeutics to Participate in 2023 Jefferies London Healthcare Conference. 22d ago. Their consensus HOOD stock forecast was that it could hit $13.36, which would represent a potential upside of 39.28% over the $9.59 closing price on 20 November, 2022. The highest Robinhood stock forecast 2023 prediction came in at $28 and the lowest warned it could slip to just $7. HOOD stock was also a ‘hold’, according to the …

Nov 29, 2023 · According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price. Feb 1, 2023 · (See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...

Nov 15, 2023 · Earnings vs Market: BEEM is forecast to become profitable over the next 3 years, which is considered above average market growth. High Growth Earnings: BEEM is expected to become profitable in the next 3 years. Revenue vs Market: BEEM's revenue (24.5% per year) is forecast to grow faster than the US market (7.7% per year). AR Stock 12 Months Forecast. Based on 13 Wall Street analysts offering 12 month price targets for Antero Resources in the last 3 months. The average price target is $33.33 with a high forecast of $38.00 and a low forecast of $25.00. The average price target represents a 15.07% change from the last price of $28.97.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Nov 29, 2023 · Beam Therapeutics (BEAM) Stock Price, News & Analysis $29.47 +1.52 (+5.44%) (As of 05:07 PM ET) Compare Today's Range $28.28 $29.84 50-Day Range $17.69 $30.76 52-Week Range $16.95 $51.60 Volume 1.35 million shs Average Volume 986,767 shs Market Capitalization $2.40 billion P/E Ratio N/A Dividend Yield N/A Price Target $48.80 Infibeam Avenues Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 5,667.88 Crore) operating in Services sector. Infibeam Avenues Ltd. key Products/Revenue Segments include Software Development Charges & Other Services for the year ending 31-Mar-2023.For the ...According to our current BEAM stock forecast, the value of Beam Therapeutics shares will drop by -2.93% and reach $ 28.70 per share by December 8, …Dec 1, 2023 · Beam Therapeutics last released its earnings results on November 8th, 2023. The reported ($1.22) earnings per share for the quarter, beating analysts' consensus estimates of ($1.33) by $0.11. The firm had revenue of $17.20 million for the quarter, compared to analyst estimates of $17.09 million. Its revenue was up 8.9% on a year-over-year basis. The Beam Therapeutics Inc. stock price gained 5.44% on the last trading day (Wednesday, 22nd Nov 2023), rising from $27.95 to $29.47. During the last trading day the stock fluctuated 5.68% from a day low at $28.24 to a day high of $29.84. The price has been going up and down for this period, and there has been a 28.69% gain for the last 2 weeks.Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...The current average BEAM price target, as estimated by these analysts, is $63.00. The predictions for the future BEAM stock price range from a low of $62.00 to a high of …

Based on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.

Nov 22, 2023 · Beam Global Stock Forecast and Price Target. In recent months, notable analysts have provided yearlong price targets for Beam Global, with the average target coming in at $18.00. If it were to be achieved, this would result in a potential upside of approximately 222 percent from the most recent closing price in November, 2023.

REINHARDT KRAUSE. 12:05 PM ET 10/25/2023. The best 5G stocks will evolve over time as business services delivered via cloud computing add new opportunities for wireless firms. But the 5G ...Nov 29, 2023 · According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest target is $32 and the highest is $105. On average, analysts rate BEAM stock stock as a buy. Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.Nov 22, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00. Beam Global has risen higher in 7 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%. Is Beam Global Stock Undervalued? The current Beam Global [ BEEM] share price is $6.02. The Score for BEEM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as reflected in the main indexes’ performances. All are down by at least double-digits; the tech-heavy NASDAQ’s 27% drop has been the most acute, while the …BEAM | Complete Beam Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.According to 4 analyst offering 12-month price targets in the last 3 months, Beam Therapeutics has an average price target of $70.25 with a high of $105.00 and a low of $37.00. Below is a summary ...Q: Investment web sites such as Yahoo list one-year price targets for stocks. How often are these correct? — Hal A: Simply put, these numbers… By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its par...

The 12 analysts offering 1 year price forecasts for BEAM have a max estimate of — and a min estimate of —. Analyst rating Based on 14 analysts giving stock ratings to BEAM in …Get The Latest CRWD Stock Analysis, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat. Skip to main content S&P 500 4,594.63 (+0.59%)Instagram:https://instagram. kruz etfasian markets nowindustry pe ratiobest prop trading firm Find real-time ADPT - Adaptive Biotechnologies Corp stock quotes, company profile, news and forecasts from CNN Business. buy dotpartial real estate investment What is the current Price Target and Forecast for Beam Therapeutics (BEAM) Beam Therapeutics (BEAM) (Delayed Data from NSDQ) $29.67 USD +0.20 (0.68%) Updated … legitimate gold sellers BEST Inc. (NYSE:BEST) announced its earnings results on Monday, August, 16th. The company reported ($22.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($14.60) by $7.60. The business had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.26 billion.The first Wood-backed stock we’ll look at is Beam Therapeutics, ... Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast)